Research programme: hetero biarylpyridoquinazolinone analogues - WyethAlternative Names: Anticancer agents research programme - Wyeth
Latest Information Update: 03 Oct 2011
At a glance
- Originator Wyeth
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 May 2000 Preclinical development for Cancer in USA (Unknown route)